Rigosertib sodium (b)

CAS No. 1225497-78-8

Rigosertib sodium (b)( ON-01910 )

Catalog No. M10864 CAS No. 1225497-78-8

Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 68 In Stock
2MG 32 In Stock
5MG 52 In Stock
10MG 92 In Stock
25MG 183 In Stock
50MG 338 In Stock
100MG 578 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rigosertib sodium (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM.
  • Description
    Rigosertib (ON-01910) is a non-ATP-competitive inhibitor of PLK1 with IC50 of 9 nM. It shows 30-fold greater selectivity against Plk2 and no activity to Plk3. Phase 3.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ON-01910
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    PLK
  • Recptor
    PLK1
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1225497-78-8
  • Formula Weight
    473.47
  • Molecular Formula
    C21H24NNaO8S
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 95 mg/mL (200.64 mM); DMSO: 95 mg/mL (200.64 mM)
  • SMILES
    COC1=C(C=C(C=C1)CS(=O)(=O)/C=C/C2=C(C=C(C=C2OC)OC)OC)NCC(=O)[O-].[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Gumireddy K, et al. Y Cell, 2005, 7(3), 275-286.
molnova catalog
related products
  • 3MB-PP1

    3MB-PP1 is an inhibitor of Polo-like kinase 1 (PLK1) and inhibits Leu93 Mutant Zipper-interacting protein kinase (Leu93-ZIPK) with an IC50 of 2 μM.

  • Dihydrobaicalein

    Dihydrobaicalein is a natural product from Scutellaria baicalensis, a PLK1 inhibitor (IC50:6.3 μM).Dihydrobaicalein inhibits VRK2 and PLK2.

  • ON1231320

    ON1231320 is a Polo-like kinase 2 (PLK2) inhibitor.